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Abstract: Curcumin, a common dietary pigment and spice, is a hydrophobic polyphenol 
derived from the rhizome of the herb Curcuma longa. Previously, we reported a cytotoxic 
effect of curcumin on mouse embryonic stem cells and blastocysts and its association with 
defects in subsequent development. In the present study, we further investigated the effects 
of curcumin on oocyte maturation and subsequent pre- and post-implantation development, 
both in vitro and in vivo. Notably, curcumin induced a significant reduction in the rate of 
oocyte maturation, fertilization, and in vitro embryonic development. Treatment of oocytes 
with  curcumin  during  in  vitro  maturation  (IVM)  led  to  increased  resorption  of 
postimplantation embryos and decreased fetal weight. Experiments with an in vivo mouse 
model disclosed that consumption of drinking water containing 40 μM curcumin led to 
decreased  oocyte  maturation  and  in  vitro  fertilization  as  well  as  early  embryonic 
developmental injury. Finally, pretreatment with a caspase-3-specific inhibitor effectively 
prevented  curcumin-triggered  injury  effects,  suggesting  that  embryo  impairment  by 
curcumin occurs mainly via a caspase-dependent apoptotic process. 
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1. Introduction 
Curcumin is used as a traditional Indian medicine [1] for the treatment of wounds, liver ailments, 
hepatitis  and  urinary  tract  diseases,  as  well  as  a  cosmetic  [2].  Curcumin  exerts  a  wide  range  of 
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pharmacological  effects,  including  anti-inflammatory,  anti-carcinogenic,  hypocholesterolemic  and 
anti-infection  activities  [3–8].  As  a  potential  antioxidant,  curcumin  displays  anti-proliferative  and 
anti-carcinogenic properties in a variety of cell lines and animals [8–12]. Moreover, the efficacy of 
curcumin in various diseases, including cancer, is well established [13]. Recent studies have shown 
that the anti-tumor activity of curcumin is attributed to its ability to induce apoptosis via caspase-3 
activation [14,15]. Moreover, various in vivo animal assay models and human studies have confirmed 
that dietary curcumin is extremely safe and does not exert hazardous effects, even at high doses [16–19]. 
For example, three separate phase I clinical trials have demonstrated that dietary curcumin administered 
at doses as high as 12 g per day is well tolerated in human [18–20]. Owing to its high pharmacological 
safety and efficacy, curcumin is a potential therapeutic candidate for the treatment and prevention of a 
wide range of human diseases.   
In a recent study, we showed that curcumin inhibits methylglyoxal-induced reactive oxygen species 
(ROS) generation and various apoptotic biochemical events in embryonic stem cells and blastocysts 
isolated from pregnant mice [21]. Another investigation by our group focusing on the possible effects 
of curcumin on ROS generation, intracellular adenosine triphosphate (ATP) levels and cell death mode 
in osteoblast cells revealed that curcumin induces apoptosis or necrosis in a dose-dependent manner [15]. 
A  more  recent  study  by  our  laboratory  showed  that  in  vitro  exposure  of  blastocysts  to  curcumin 
triggers  apoptosis  and  retards  early  postimplantation  development  after  transfer  to  host  mice.   
In addition, curcumin induces apoptotic injury effects on mouse blastocysts through ROS generation 
and  further  promotes  mitochondria-dependent  apoptotic  signaling  processes  to  impair  sequent 
embryonic development [22]. However, while multiple biological functions have been identified for 
curcumin, the ambiguous issue of its activity as an apoptotic inducer or inhibitor and the precise 
molecular mechanisms underlying these actions are yet to be fully determined. To date, no studies 
have investigated the potential of curcumin as a cytotoxic agent against oocyte maturation, fertilization 
and sequent embryonic development. 
Oocyte viability is affected by the microenvironment during growth and maturation. Heat stress, 
oxygen concentration and glucose content are key determinants of oocyte viability [23–25]. A number 
of researchers have investigated the influence of environmental biological toxins on oocyte maturation 
in vivo and in vitro. During normal embryogenesis, apoptosis (a unique morphological pattern of cell 
death) functions to remove abnormal or redundant cells in preimplantation embryos [26,27]. However, 
apoptotic  processes  do  not  occur  prior  to  the  blastocyst  stage  during  normal  mouse  embryonic 
development  [28],  and  induction  of  cell  death  during  oocyte  maturation  and  early  stages  of 
embryogenesis (i.e., via exposure to a teratogen) leads to embryonic developmental injury [21,24,29–31]. 
Previous  studies  by  our  group  have  demonstrated  that  curcumin  promotes  cell  apoptosis  and 
developmental injury in blastocyst stage embryos [22]. However, the influence of curcumin on early 
stage  embryogenesis  processes,  such  as  oocyte  maturation,  fertilization,  and  sequential  embryo 
development from zygotes, is currently unclear. Here, we further investigated whether curcumin exerts 
a hazardous effect on oocyte development by incubating oocytes with the compound for 24 h and 
comparing sequential development with that of oocytes under curcumin-free conditions. We aimed to 
determine whether short-term  exposure to  curcumin at  the oocyte stage has a long-term  injurious 
impact on embryo development. Our results clearly demonstrate that curcumin exposure during the Int. J. Mol. Sci. 2012, 13  4657 
 
oocyte  stage  not  only  inhibits  oocyte  maturation  but  also  promotes  injurious  effects  on  in  vitro 
fertilization and embryonic development. 
2. Results and Discussion 
Although recent studies have established that curcumin induces apoptosis and developmental injury 
in  mouse  blastocysts  [22],  its  effects  on  oocyte  maturation  are  currently  unclear.  Oocyte  nuclear 
maturation  status  was  measured  using  12  independent  experimental  replicates  (~220  oocytes  per 
group). The majority of oocytes reached the metaphase II (MII) stage of maturation after IVM (ranging 
to about 94.7%). A lower maturation rate was observed in the 20 μM curcumin-treated oocyte group 
(Figure 1). Male pronucleus formation was assessed for the detection of fertilization. Notably, the 
ability of oocytes to be fertilized by fresh sperm was significantly decreased upon pretreatment with   
20 μM curcumin prior to IVM (Figure 1). 
Figure  1.  Effects  of  curcumin  on  mouse  oocyte  maturation  and  embryo  development   
in  vitro.  Oocytes  were  collected  from  21  day-old  mice,  cultured  for  24  h  in  in  vitro 
Maturation (IVM) medium containing curcumin (Cur; 5, 10 or 20 μM), fertilized in vitro, 
and transferred to in vitro culture (IVC) medium. Oocyte maturation, in vitro fertilization, 
cleavage and blastocyst development were analyzed. Values are presented as means ±  SEM 
of eight determinations. Data are based on 250–300 samples per group. *** P < 0.001 
versus the untreated control group. 
 
We further analyzed in vitro embryo development to the two-cell and blastocyst stages. Curcumin 
(20 μM) pretreatment led to a significant decrease in cleavage of oocytes to the two-cell stage, indicative 
of an injurious effect (Figure 1). In addition, the number of embryos that cleaved to form blastocysts in 
20 μM curcumin-treated group was significantly lower than that in untreated control groups (Figure 1). 
Following curcumin treatment during IVM of oocytes, total blastocyst cell numbers were counted, 
with a view to  establishing  its  effects on cell proliferation. Differential staining, followed by cell 
counting, was employed to assess cell proliferation. Significantly lower blastocyst cell numbers were 
derived  from  20  μM  curcumin-pretreated  oocytes,  compared  to  control  oocytes  (Figure  2A). 
Additionally, the number of ICM cells in blastocysts decreased during IVM after pretreatment with   
20 μM curcumin (Figure 2A). Curcumin did not affect the number of trophectoderm (TE) cells present 
in blastocysts (Figure 2A). Int. J. Mol. Sci. 2012, 13  4658 
 
Apoptosis  of  blastocysts  derived  from  20  μM  curcumin-pretreated  oocytes  was  additionally 
evaluated. TUNEL staining revealed a dose-dependent increase in apoptosis of blastocysts derived 
from the 20 μM curcumin-pretreated oocyte group (Figure 2B). Further quantitative analysis showed a 
~9-fold increase in apoptotic blastocysts derived from 20 μM curcumin-pretreated oocytes, compared 
to the control group (Figure 2C). 
Figure 2. Effects of curcumin on cell number and apoptosis in embryos during IVM of 
oocytes. Oocytes were cultured for 24 h in IVM medium containing curcumin (Cur; 5, 10 
or 20 μM), fertilized in vitro, and transferred to in vitro culture (IVC) medium for in vitro 
development. (A) Cell numbers of total, trophectoderm (TE) lineages and inner cell mass 
(ICM) were counted in blastocysts; (B) Apoptotic cells were examined at the blastocyst 
stage using TUNEL staining, followed by light microscopy. Positive cells are depicted in 
black;  (C)  The  mean  number  of  apoptotic  (TUNEL-positive)  cells  per  blastocyst  was 
calculated. Values are presented as means ±  SEM of six replicates. Data are based on at 
least 300 samples in each group. *** P < 0.001 versus the untreated control group. 
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Embryos were transferred to 54 recipients per group (8 per horn). A total of 40 recipients were 
pregnant in at least one horn at day 18. The implantation ratio of blastocysts derived from the oocyte 
group treated with 20 μM curcumin during IVM was ~30%, which was significantly lower than that 
observed for control blastocysts (~79%) (Figure 3A). 
Embryos  that  implanted  but  failed  to  develop  were  subsequently  resorbed  in  the  uterus.   
The proportion of implanted embryos that failed to develop normally was significantly higher in the   
20 μM curcumin-treated group (~73%), compared to the control group (~33.6%) (Figure 3A). In terms 
of embryo survival rate (surviving fetuses), 66.4% of the control group survived to post-coitus day 18, 
compared to only 26.8% of the 20 μM curcumin-treated group (Figure 3A). Interestingly, however, the 
placental  weights  of  blastocysts  derived  from  20  μM  curcumin-treated  oocytes  in  IVM  were  not 
significantly different from those of the control group (Figure 3B). Importantly, fetal weights were 
lower in the groups treated with 20 μM curcumin, relative to the untreated control group. Furthermore, 
only 10.7% of fetuses in the 20 μM curcumin-pretreated group weighed over 600 mg, an important 
indicator of successful embryonic and fetal development, whereas 28.9% of control fetuses exceeded 
this threshold (Figure 3C). Our findings collectively indicate that exposure of oocytes to curcumin 
during IVM reduces the potential of postimplantation development. 
In view of the injurious effects of curcumin on oocyte maturation and embryo development in vitro, 
we analyzed curcumin activity in vivo via intake in an animal model. Female mice were fed a standard 
diet and drinking water supplemented with curcumin (10–40 μM) for 4 days or left untreated, prior to 
COC collection. Oocyte maturation status, fertilization rate, and in vitro embryo development were 
evaluated. Dietary curcumin at a concentration of 40 μM induced a significant decrease in oocyte 
maturation  and  fertilization,  resulting  in  inhibition  of  embryonic  development  from  the  zygote  to 
blastocyst stage (Figure 3D). Int. J. Mol. Sci. 2012, 13  4660 
 
Figure  3.  Effects  of  curcumin  treatment  or  dietary  curcumin  on  embryo  development 
during oocyte IVM. Oocytes were cultured for 24 h in IVM medium containing curcumin 
(Cur; 5, 10 or 20 μM), fertilized in vitro, and transferred to in vitro culture medium for 
development.  (A)  Implantation,  resorption  and  surviving  fetuses  were  analyzed,  as 
described in Materials and Methods. The implantation percentage represents the number of 
implantations per number of transferred embryos ×  100. The percentage of resorbed or 
surviving fetuses represents the number of resorptions or surviving fetuses per number of 
implantations  ×   100;  (B)  Placental  weights  of  40  recipient  mice  were  measured;   
(C) Weight distribution of surviving fetuses at day 18 post-coitus. Surviving fetuses were 
obtained by embryo transfer of control and curcumin-pretreated groups, as described in 
Materials and Methods (320 total blastocysts across 40 recipients); (D) Random female 
mice (21 day-old) were fed a standard diet and drinking water supplemented with curcumin 
(10–40 μM) for 5 days or left untreated. Oocytes were collected for in vitro maturation,   
in vitro fertilization, cleavage, and blastocyst development analyses. Data are based on at 
least 400 samples in each group. *** P < 0.001 versus the curcumin-free group. 
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(D) 
To  further  determine  the  effects  of  curcumin  on  embryo  implantation  and  post-implantation 
development,  we  analyzed  curcumin  activity  in  vivo  via  intake  and  transfer  of  blastocyst  stage 
embryos to the uterus horn using the embryo transfer assay in an animal model. Female mice were fed 
a standard diet and drinking water continuously supplemented  with curcumin (10–40 μM) or left 
untreated for 4 days before embryo transfer to the uterus during the experimental period. Embryos 
were transferred to 48 recipients per group (8 per horn). A total of 40 recipients were pregnant at   
day  18.  Notably,  the  implantation  ratio  of  blastocysts  in  the  40  μM  curcumin-intake  group  was 
significantly lower than that of blastocysts in the curcumin-free control group (Figure 4A). Moreover, 
the  40 μM  curcumin  intake  group displayed  a  higher overall resorption  rate (Figure  4A)  and  the 
embryo survival rate was markedly lower than that of curcumin-free group (Figure 4A). However, the 
placental  weights  of  blastocysts  derived  from  the  curcumin-intake  group  were  not  significantly 
different from those of the control group (data not shown). Finally, fetal weights were lower in the 
curcumin  intake  (40  μM)  than  the  untreated  control  group  (Figure  4B).  Our  results  collectively 
demonstrate that exposure of embryos to 40 μM curcumin reduces the potential of implantation and 
postimplantation development. Int. J. Mol. Sci. 2012, 13  4662 
 
Figure  4.  Effects  of  dietary  curcumin  on  embryo  development  in  mouse  blastocysts. 
Random  female  mice  (21  day-old)  were  fed  a  standard  diet  and  drinking  water 
continuously supplemented with curcumin (10–40 μM) or left untreated for 4 days before 
embryo transfer to the uterus during the experimental period. (A) Implantation, resorption 
and  surviving  fetuses  were  analyzed,  as  described  in  Materials  and  Methods.  The 
implantation percentage represents the number of implantations per number of transferred 
embryos ×  100. The percentage of resorbed or surviving fetuses represents the number of 
resorptions or surviving fetuses per number of implantations ×  100; (B) Weight distribution 
of surviving fetuses at  day 18 post-coitus. Surviving fetuses were obtained by embryo 
transfer of control and curcumin intake groups, as described in Materials and Methods   
(320 total blastocysts across 40 recipients). *** P < 0.001 versus the curcumin-free group. 
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To further clarify the regulatory mechanisms underlying curcumin activity, oocytes were pretreated 
with  300  μM  Ac-DEVD-cho,  a  caspase-3  specific  inhibitor,  with  the  aim  of  preventing 
curcumin-triggered  embryo  cell  apoptosis  during  IVM.  Pretreatment  with  the  caspase-3  inhibitor 
effectively prevented apoptosis of cells within the blastocysts derived from the oocyte group pretreated 
with 20 μM curcumin (Figure 5A). Consistently, the caspase-3 inhibitor blocked curcumin-triggered 
hazardous effects on oocyte maturation, fertilization rate, and sequential embryo development during 
IVM (Figure 5B). Treatment with the caspase-3 inhibitor additionally rescued the curcumin-induced 
reduction in postimplantation development potential by embryo transfer, including embryo implantation Int. J. Mol. Sci. 2012, 13  4663 
 
and fetal survival rates (Figure 5C). These results strongly indicate that the mechanisms underlying 
curcumin regulation of oocyte development during IVM involve apoptotic processes.   
Figure  5.  Effects  of  inhibition  of  cell  apoptosis  on  embryo  development  in  curcumin 
treatment during oocyte IVM. Oocytes were collected from 21 day-old mice, cultured for 
24 h in IVM medium alone or containing 300 μM Ac-DEVD-cho and 20 μM curcumin 
(Cur), fertilized in vitro, and transferred to in  vitro culture (IVC) medium for  in vitro 
development.  (A)  Apoptotic  cells  were  examined  at  the  blastocyst  stage  via  TUNEL 
staining; (B) Oocyte maturation, in vitro fertilization, cleavage and blastocyst development 
were analyzed; (C) Implantation, resorption, and surviving fetuses were analyzed with the 
embryo transfer assay, as described for Figure 3. Data are based on at least 250 samples in 
each  group.  ***  P  <  0.001  versus  the  untreated  control  group; 
#  P  <  0.001  versus 
curcumin-treated group. 
 
(A) 
 
(B) Int. J. Mol. Sci. 2012, 13  4664 
 
Figure 5. Cont. 
 
(C) 
Real-time RT-PCR revealed that the levels of mRNA encoding p53 and p21 were significantly 
upregulated in cells of blastocysts from oocytes pretreated with 20 μM curcumin (Figure 6A). To 
further explore the functions of p53 and p21 in terms of curcumin-induced apoptosis, we used targeted 
siRNAs to suppress p53 expression in blastocyst cells derived from oocytes. Knockdown with p53 
siRNA significantly decreased the levels of mRNA encoding p53 and p21 in blastocyst cells derived 
from  oocytes  pretreated  with  20  μM  curcumin  (Figure  6A);  this  was  accompanied  by  a  marked 
decrease in the extent of curcumin-induced apoptosis (Figure 6B). The results indicate that curcumin 
upregulates the levels of p53 and p21 in blastocyst cells derived from curcumin-pretreated oocytes; 
apoptosis is subsequently promoted. Thus, regulation of apoptosis in blastocyst cells derived from 
curcumin-treated oocytes involves  p53-dependent  biochemical  processes;  embryo implantation and 
fetal survival rates are subsequently affected. 
Figure 6. Knockdown of p53 protects blastocyst cells against curcumin-induced apoptosis. 
Mouse oocytes were transfected with siRNA targeting p53, incubated for 24 h, and treated 
with 20 μM curcumin (Cur) for a further 24 h. (A) The mRNA levels of p53 and p21 were 
analyzed  using  real-time  PCR;  (B)  Apoptosis  was  measured  as  described  in  Figure  1.   
*** P  <  0.001 versus  the untreated control  group; 
# P < 0.001  versus the “curcumin- 
treated” group. 
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Previous studies by our group have shown that curcumin induces osteoblast apoptosis at doses of 
12.5–25 μM and necrosis at doses greater than 50 μM [15]. Interestingly, curcumin is able to both 
stimulate  and  inhibit  apoptotic  signaling.  For  instance,  curcumin  induces  apoptosis  in  human 
melanoma  (30–60  μM  for  24  h)  [32],  human  leukemia  HL  60  (10–40  μM  for  16–24  h)  [33,34],   
AK-5  tumor  (10  μM  for  18  h)  [14,35]  and  MCF-7  breast  cancer  cells  (25  μM  for  24  h)  [36]. 
Conversely, curcumin (10 μM for 12 h) inhibits dexamethasone-induced apoptosis in rat thymocytes, 
chemotherapy-induced apoptosis in breast cancer cells [37,38], and methylglyoxal-triggered apoptosis 
in mouse embryonic stem cells  [21]. Our novel results, along with previously published findings, 
indicate  that  the  treatment  protocol  (i.e.,  treatment  period  and  dosage)  determines  the  effects  of 
curcumin on various cell types. A recent study by our group further demonstrated that curcumin triggers 
apoptosis in ICM cells of mouse blastocysts, leading to impairment of embryo development via ROS 
generation,  which  in  turn  stimulates  downstream  processes  through  the  mitochondria-dependent 
pathway [22]. In the present study, we further investigated whether curcumin exerts possible cytotoxic 
effects on oocyte maturation, fertilization, and sequential embryo development. 
Oocyte maturation, fertilization, and embryonic development are complex processes during which 
chemical  injury  can  lead  to  developmental  problems  or  embryonic  malformation.  Previously,  we 
showed that curcumin induces apoptosis, impairment of blastocyst development from the morula, and 
promotion of early-stage death of mouse blastocysts [22]. Thus, it is important to establish the possible 
teratogenic effects of curcumin. In this study, we demonstrate for the first time that curcumin inhibits 
mouse oocyte maturation, fertilization, and sequential embryonic development (Figure 1). Importantly, 
the  curcumin-pretreated  oocyte  group  displayed  significantly decreased  cell number and increased 
apoptosis (Figure 2A,B). The results collectively indicate that curcumin treatment at the oocyte stage 
triggers both  oocyte maturation injury  and abnormal  apoptosis  of cells at  the blastocyst  stage, an 
important step in embryo implantation. 
The TE arises from the trophoblast at the blastocyst stage and develops into a sphere of epithelial 
cells surrounding the ICM and blastocoel. These cells contribute to the placenta and are required for 
mammalian conceptus development [39]. Reduction in cells of the TE and/or ICM lineage leads to 
suppressed implantation and lower embryonic viability  [40,41]. The ICM and total blastocyst cell Int. J. Mol. Sci. 2012, 13  4666 
 
numbers are positively correlated with embryonic development during the embryo transfer assay [42]. 
Application of curcumin during oocyte maturation had no effect on the TE cell number of blastocysts, 
but led to a dramatic decrease in ICM and total (TE plus ICM) cell numbers (Figure 2). These results 
imply  that  curcumin  treatment  during  IVM  causes  mortality  and/or  developmental  delay  in 
postimplantation mouse embryos via ICM cell death or a decrease in proliferation (Figures 2 and 3). 
Interestingly,  blastocysts  derived  from  curcumin-treated  oocytes  appeared  to  undergo  decreased 
implantation, increased embryo resorption, and a lower fetal survival rate (Figure 3A), but exhibited 
comparable  placental  weight  to  the  control  group.  TE  cells  of  embryos  play  important  roles  in 
implantation and placental development. Our results indicate that curcumin does not exert a hazardous 
effect on TE cells of blastocysts and consequently does not affect placental development. Based on the 
data, we propose that the decrease in ICM cell number induced by curcumin during oocyte maturation 
is the major injurious factor leading to inhibition of embryonic development. 
Our results show that curcumin-pretreated oocytes display significantly decreased fertilization rates 
and cleavage to the two-cell and blastocyst stages, compared to the untreated control groups (Figure 1), 
indicating that curcumin induces loss of fertilization and sequent embryonic development. Moreover, 
in  an  embryo  transfer  study,  mouse  blastocyst  stage  embryos  derived  from  curcumin-pretreated 
oocytes  displayed  lower  implantation  and  higher  resorption  rates  than  control  blastocyst-derived 
untreated oocytes (Figure 3A). Further experiments disclosed lower embryo implantation rates and 
fetal weights and a higher resorption rate of blastocyst stage embryo transfer to the mouse uterus in the 
40 μM curcumin-intake group, distinct from those of the curcumin-free control group (Figure 4A,B). 
These  results  collectively  indicate  that  curcumin  has  potentially  hazardous  effects  on  early-stage 
oocyte maturation and fertilization. Importantly, exposure of blastocyst embryos to curcumin reduces 
the potential of embryo implantation and postimplantation development. 
During  embryonic  development,  cells  are  often  poised  between  proliferation  and  apoptosis. 
Curcumin is cytotoxic to human osteoblasts and mouse blastocysts [15,22]. The compound induces 
apoptosis via activation of mitochondrial processes and caspases, which are the predominant pathways 
during oxidative stress-mediated cell injury [15,22]. Experiments from the present study showed that 
pretreatment  of  oocytes  with  curcumin  leads  to  decreased  cell  number,  apoptosis,  and  delay  in 
postimplantation development of blastocysts, compared to the control group. These injurious effects 
were prevented by pretreatment of oocytes with a caspase-3 inhibitor to suppress blastocyst apoptosis 
(Figure 5). Treatment with the caspase-3 inhibitor additionally rescued curcumin-induced reduction in 
postimplantation development potential following embryo transfer, including embryo implantation rate, 
fetal survival rate, and fetal development status. Our results indicate that curcumin triggers improper 
cell  apoptotic  processes  in  early-stage  embryos,  leading  to  loss  of  embryo  cell  numbers  and 
suppression  of  post-implantation  development,  further  supporting  its  role  as  a  teratogen  through 
apoptosis induction in early-stage embryonic cells. Moreover, in the current study, we found that the 
levels of mRNA encoding p53 and p21 were upregulated in mouse blastocysts derived from oocytes 
pretreated with curcumin (Figure 6A). Further, siRNA-mediated knockdown of p53-encoding mRNA 
inhibited the curcumin-induced increase in the level of mRNA encoding p21 and decreased the extent 
of subsequent apoptosis (Figure 6A,B). These results indicate that p53 and p21 play apoptotic roles in 
mouse blastocyst cells derived from curcumin-treated oocytes. Int. J. Mol. Sci. 2012, 13  4667 
 
3. Experimental Section 
3.1. Chemicals and Reagents 
Dulbecco’s modified Eagle’s medium (DMEM), curcumin, and pregnant mare serum gonadotropin 
(PMSG) were obtained from Sigma (St. Louis, MO, USA). Human chorionic gonadotropin (hCG) was 
purchased from Serono (NV Organon, Oss, The Netherlands). TUNEL in situ cell death detection kits 
were  acquired  from  Roche  (Mannheim,  Germany),  and  CMRL-1066  medium  from  Gibco  Life 
Technologies (Grand Island, NY, USA). 
3.2. COC Collection and in Vitro Maturation (IVM) 
ICR mice were acquired from the National Laboratory Animal Center (Taiwan). This research was 
approved by the Animal Research Ethics Board of Chung Yuan Christian University (Taiwan). All 
animals  received  humane  care,  as  outlined  in  the  Guidelines  for  Care  and  Use  of  Experimental 
Animals  (Canadian  Council  on  Animal  Care,  Ottawa,  Canada,  1984).  Mice  were  maintained  on 
breeder chow (Harlan Teklad chow) with food and water available ad libitum. Housing was provided 
in standard 28 cm ×  16 cm ×  11 cm (height) polypropylene cages with wire-grid tops, and maintained 
under a 12 h day/12 h night regimen. Cumulus-oocyte complexes (COCs) were obtained according to a 
previous  protocol  [24]. Briefly,  COCs  were  isolated  from  female  hybrid  ICR  mice  (21  days  old) 
injected with 5 IU human chorionic gonadotrophin (hCG) 44 h prior to oocyte collection. COCs were 
collected in HEPES-buffered α minimum essential medium (MEM) (containing 50 μg/mL Streptomycin 
sulfate, 75 μg/mL Penicillin G, and 5% fetal bovine serum) by gently puncturing visible antral follicles 
present on the ovary surface. Germinal vesicle stage oocytes containing an intact vestment of cumulus 
cells were collected and pooled in at least 8 animals. For oocyte maturation, one drop (~100 μL) of 
buffer (α minimum essential medium supplemented with 50 μg/mL Streptomycin, 75 μg/mL Penicillin 
G, 5% FBS and 50 mIU/mL recombinant human FSH) containing 10 COCs was added under oil in 35 
mm  culture  dishes.  COC  maturation  was  analyzed  following  treatment  with  or  without  various 
concentrations of curcumin (5, 10 or 20 μM) for 24 h under an atmosphere of 5% O2, 6% CO2 and 
balance of N2 at 37 °C . 
3.3. Maturation Status Assessment 
After in vitro maturation (IVM), COCs of each group were treated with 50 U/mL ovine hyaluronidase 
and gently pipetted for the removal of all cumulus cells. Denuded oocytes were collected, and washed 
with  fresh  medium,  followed by phosphate-buffered saline (PBS). Oocytes  were fixed in  ethanol: 
glacial acetic acid (1:3) for 48 h, and stained with 1% aceto-orcein solution. Nuclear structures were 
visualized using phase-contrast microscopy. 
3.4. In Vivo Maturation 
For obtaining in vivo matured oocytes, 21 day-old mice were injected with 5 IU equine chorionic 
gonadotrophin (eCG) and 5 IU hCG, 61 and 13 h prior to fertilization, respectively. Mature ova were 
collected from the oviduct into HEPES-buffered α MEM medium. Int. J. Mol. Sci. 2012, 13  4668 
 
3.5. Effects of Curcumin Intake on Oocyte Maturation in an Animal Model   
The effects of curcumin on oocytes were analyzed in 21 day-old ICR virgin albino mice. Female 
mice were randomly divided into two groups of 20 animals each, and administered a standard diet with 
or without 10–40 μM curcumin in drinking water for 4 days. COCs were collected by pre-treatment 
with 5 IU human chorionic gonadotrophin (hCG) for 44 h prior to oocyte collection, and analyzed for 
oocyte maturation, in vitro fertilization, and embryonic development. 
3.6. In Vitro Fertilization 
For in vitro fertilization, ova were washed twice in bicarbonate-buffered α-MEM medium (containing 
50 mg/mL Streptomycin, 75 mg/mL Penicillin G and 3 mg/mL fatty acid free bovine serum albumin), 
and fertilized in the same medium with fresh sperm (obtained from a CBAB6F1 male donor). After 
incubation with sperm for 4.5 h, eggs were washed three times in potassium simplex optimized medium 
(KSOM) without amino acids in the presence of  L-alanyl-L-glutamine (1.0 mM). Next, eggs were 
placed in 20 mL drops of KSOM under oil, and cultured overnight. During cleavage to the 2-cell stage, 
embryos were transferred to a fresh drop of KSOM under oil, and cultured for another 72 h. All 
fertilization steps and embryo culture were additionally carried out under 5% O2, 6% CO2 and balance 
of N2 at 37 °C . 
3.7. Fertilization Assessment 
For the examination of fertilization, ova were incubated with sperm for 4.5 h, followed by 3 h of 
culture in fresh medium. Zygotes were assessed for the presence of the male pronucleus with orcein 
staining, as described previously [24]. 
3.8. Cell Proliferation 
Cell proliferation was analyzed by dual differential staining, which facilitated the counting of cell 
numbers in inner cell mass (ICM) and trophectoderm (TE) [40,43,44]. Blastocysts were incubated with 
0.4%  pronase  in  M2–BSA  medium  (M2  medium  containing  0.1%  bovine  serum  albumin)  for  the 
removal of zona pellucida. Denuded blastocysts were exposed to 1 mM trinitrobenzenesulfonic acid 
(TNBS) in BSA-free M2 medium containing 0.1% polyvinylpyrrolidone (PVP) at 4 °C  for 30 min, and 
washed with M2 [45]. Blastocysts were further treated with 30 μg/mL anti-dinitrophenol-BSA complex 
antibody in M2-BSA at 37 °C  for 30 min, followed by M2 supplemented with 10% whole guinea pig 
serum as a source of complement, along with 20 μg/mL bisbenzimide and 10 μg/mL propidium iodide 
(PI) at 37 °C  for 30 min. The immunolysed blastocysts were gently transferred to slides, and protected 
from light before observation. Under UV light, ICM cells (which take up bisbenzimidine but exclude 
PI) appeared blue, whereas TE cells (which take up both fluorochromes) appeared orange-red. Since 
multinucleated cells are not common in preimplantation embryos [46], the number of nuclei represent 
an accurate measurement of cell number. Int. J. Mol. Sci. 2012, 13  4669 
 
3.9. TUNEL Assay of Blastocysts 
For TUNEL staining, embryos were washed in curcumin-free medium, fixed, permeabilized, and 
subjected  to  labeling  using  an  in  situ  cell  death  detection  kit  (Roche  Molecular  Biochemicals, 
Mannheim, Germany), according to the manufacturer’s protocol. Photographic images were obtained 
with a fluorescence microscope under bright-field illumination. 
3.10. Blastocyst Development Following Embryo Transfer 
To determine the ability of expanded blastocysts to implant and develop in vivo, embryos generated 
were  transferred  to  recipient  mice.  ICR  females  (6–8  week-old,  white  skin)  were  mated  with 
vasectomized males (C57BL/6J; black skin; National Laboratory Animal Center, Taiwan) to produce 
pseudopregnant dams as recipients for embryo transfer. To ensure that all fetuses in pseudopregnant 
mice were derived from embryo transfer (white color) and not fertilization by C57BL/6J (black color), 
we examined skin color at day 18 post-coitus. To assess the impact of curcumin on postimplantation 
growth in vivo, COCs were exposed to 0–20 μM curcumin for 24 h, followed by fertilization and   
in vitro maturation to the blastocyst stage. Subsequently, 8 untreated control embryos were transferred 
to  the  left  uterine  horn,  and  8  curcumin-treated  embryos  to  the  right  uterine  horn  in  day  4 
pseudopregnant mice. Forty surrogate mice were analyzed and killed on day 18 post-coitus, and the 
frequency  of  implantation  calculated  as  the  number  of  implantation  sites  per  number  of  embryos 
transferred. The incidence rates of resorbed and surviving fetuses were calculated as number of fetuses 
per number of implantations, respectively. The weights of the surviving fetuses and placenta were 
measured immediately after dissection. 
3.11. Statistical Analysis 
Data were analyzed using one-way ANOVA and t-tests, and presented as means ±  SEM. Data were 
considered statistically significant at P < 0.05. 
4. Conclusions 
Based on our study results, we propose that developmental injury by curcumin occurs via induction 
of apoptosis processes in oocyte maturation and early-stage embryos. We show for the first time that 
curcumin exerts injurious effects on oocyte maturation, fertilization, and embryonic development. Our 
findings clearly suggest that curcumin is a risk factor for normal embryonic development and possibly 
suppresses oocyte maturation in infertile couples. Further studies are required to ascertain the possible 
teratogenic actions of curcumin on human oocyte maturation and embryogenesis. 
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